Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.

These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.

Launch Date: March 27, 2025

Release Date: March 27, 2025

Expiration Date: February 28, 2026

FACULTY

Alice Gottlieb, MD, PhD

Clinical Professor, Icahn School of Medicine at Mount Sinai

Mark Lebwohl, MD

Dean for Clinical Therapeutics

Icahn School of Medicine at Mount Sinai

Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology

Mount Sinai Health System

Philip Mease, MD

Director, Rheumatology Research, Providence Swedish Medical

Clinical Professor, University of Washington School of Medicine

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.

These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.

Launch Date: March 27, 2025

Release Date: March 27, 2025

Expiration Date: February 28, 2026

FACULTY

Alice Gottlieb, MD, PhD

Clinical Professor, Icahn School of Medicine at Mount Sinai

Mark Lebwohl, MD

Dean for Clinical Therapeutics

Icahn School of Medicine at Mount Sinai

Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology

Mount Sinai Health System

Philip Mease, MD

Director, Rheumatology Research, Providence Swedish Medical

Clinical Professor, University of Washington School of Medicine

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.

These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.

Launch Date: March 27, 2025

Release Date: March 27, 2025

Expiration Date: February 28, 2026

FACULTY

Alice Gottlieb, MD, PhD

Clinical Professor, Icahn School of Medicine at Mount Sinai

Mark Lebwohl, MD

Dean for Clinical Therapeutics

Icahn School of Medicine at Mount Sinai

Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology

Mount Sinai Health System

Philip Mease, MD

Director, Rheumatology Research, Providence Swedish Medical

Clinical Professor, University of Washington School of Medicine

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Vitiligo is a relatively common acquired pigmentation disorder. The therapeutic effect of all the treatment modalities varies considerably from individual to individual. As such, treatment must be individualized. Moreover, vitiligo can carry significant psychosocial impact. Healthcare providers play a crucial role in shaping patients' understanding of their condition, approach to treatment, and coping mechanisms. In this podcast series, Dr. Raj Chovatiya, along with his patient, will discuss ways to individualized treatment strategies and improve holistic care of patients with vitiligo.

Launch Date: November 21, 2024

Release Date: November 21, 2024

Expiration Date: October 31, 2025

FACULTY

Raj Chovatiya, MD, PhD, MSCI, FAAD

Clinical Associate Professor

Rosalind Franklin University Chicago Medical School

Founder and Director

Center for Medical Dermatology + Immunology Research

Chicago, IL

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.

https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo

Vitiligo is a relatively common acquired pigmentation disorder. The therapeutic effect of all the treatment modalities varies considerably from individual to individual. As such, treatment must be individualized. Moreover, vitiligo can carry significant psychosocial impact. Healthcare providers play a crucial role in shaping patients' understanding of their condition, approach to treatment, and coping mechanisms. In this podcast series, Dr. Raj Chovatiya, along with his patient, will discuss ways to individualized treatment strategies and improve holistic care of patients with vitiligo.

Launch Date: November 14, 2024

Release Date: November 14, 2024

Expiration Date: October 31, 2025

FACULTY

Raj Chovatiya, MD, PhD, MSCI, FAAD

Clinical Associate Professor

Rosalind Franklin University Chicago Medical School

Founder and Director

Center for Medical Dermatology + Immunology Research

Chicago, IL

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.

https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo

Estimated to impact at least 125 million people worldwide, the burden of living with psoriasis runs more than skin deep. From the physical impact and comorbidities to the emotional toll that may plague everyday life, many patients still struggle with inadequate disease control, often going untreated or undertreated, despite the myriad treatment options available. There is a significant need for new psoriasis treatment options, and this interactive program is designed to provide expert interpretation of new and emerging data on the treatment of psoriasis, with multidisciplinary expert perspectives on how new agents can impact clinical practice. This podcast will discuss how to help clinicians select the most appropriate treatment as well as address the significant health burdens and comorbidities experienced by many patients with psoriasis.

Launch Date: August 15, 2024

Release Date: August 15, 2024

Expiration Date: July 31, 2025

FACULTY

Bruce Strober, MD, PhD

Clinical Professor

Yale University and Central Connecticut University

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.

https://www.practicepointcme.com/CMEHome/optimizing-outcomes-in-psoriasis-exploring-the-impact-of-rapid-diagnosis-and-emerging-therapeutic-agents

Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.

Launch Date: July 26, 2024

Release Date: July 26, 2024

Expiration Date: June 30, 2025

FACULTY

Timothy Craig, DO, FAAAAI, FACP, FACAAI, FACOI

Tenured Professor of Medicine

Pediatrics and Distinguished Educator

Pennsylvania State University

Marc Riedl, MD, MS

Professor of Medicine

University of California, San Diego

Clinical Director - US HAEA Angioedema Center

University of California, San Diego

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this

podcast.https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1

Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.

Launch Date: July 26, 2024

Release Date: July 26, 2024

Expiration Date: June 30, 2025

FACULTY

Timothy Craig, DO, FAAAAI, FACP, FACAAI, FACOI

Tenured Professor of Medicine

Pediatrics and Distinguished Educator

Pennsylvania State University

Marc Riedl, MD, MS

Professor of Medicine

University of California, San Diego

Clinical Director - US HAEA Angioedema Center

University of California, San Diego

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this

podcast.https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1

Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.

Launch Date: July 26, 2024

Release Date: July 26, 2024

Expiration Date: June 30, 2025

FACULTY

Timothy Craig, DO, FAAAAI, FACP, FACAAI, FACOI

Tenured Professor of Medicine

Pediatrics and Distinguished Educator

Pennsylvania State University

Marc Riedl, MD, MS

Professor of Medicine

University of California, San Diego

Clinical Director - US HAEA Angioedema Center

University of California, San Diego

This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this

podcast.https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1

This is an accredited continuing education series of two (2) podcasts as downloadable audio files (MP3). In this podcast series, Dr. Scott Canna and Dr. Alexei Grom discuss diverse mechanisms and clinical presentations in patients with suspected MAS, approaches for the timely diagnosis of MAS, and considerations for appropriate treatment and management strategies.

Launch Date: December 21, 2023

Release Date: December 21, 2023

Expiration Date: November 30, 2024

FACULTY

Scott Canna, MD

Assistant Professor of Pediatrics

University of Pennsylvania Perelman School of Medicine

Attending Physician, Rheumatology and Immune Dysregulation

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania

Alexei Grom, MD

Professor of Pediatrics

Research Director

Division of Rheumatology

Cincinnati Children’s Hospital Medical Center

Cincinnati, Ohio

This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.

https://www.practicepointcme.com/CMEHome/expert-insights-on-mas-sjiaaosd-and-macrophage-activation-syndrome-an-interactive-case-based-discussion-37